Companies Tectonic Therapeutic, Inc.
Tectonic Therapeutic (AVRO): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Tectonic Therapeutic, Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask; press Download and a copy goes to your email too. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $5,900,217FY2024
- $7,351,578FY2025
CEO total pay was $7,351,578 in fiscal 2025, up from $5,900,217 in fiscal 2024.
FY2025: salary $640,833 · bonus $0 · stock awards $1,946,853 · option awards $4,373,617
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Alise Reicin | $640,833 | $0 | $1,946,853 | $4,373,617 | $372,500 | $0 | $17,775 | $7,351,578 |
| President, CEO and Director | ||||||||
| Daniel Lochner | 488,854 | 0 | 947,608 | 1,424,794 | 206,500 | 0 | 33,358 | 3,101,114 |
| Chief Financial Officer | ||||||||
| Marcella Ruddy | 501,050 | 0 | 937,219 | 1,409,161 | 211,700 | 0 | 10,500 | 3,069,630 |
| Chief Medical Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Alise Reicin | $7,351,578 | $5,900,217 | — | ↑ +1,451,361 |
| Daniel Lochner | 3,101,114 | 2,284,007 | — | ↑ +817,107 |
| Marcella Ruddy | 3,069,630 | 1,840,150 | — | ↑ +1,229,480 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company aims to provide executive officers with a reasonable level of security through base salary and benefits, while rewarding them through cash and equity-based incentive compensation to achieve business objectives and create stockholder value. The compensation components are designed to provide a reasonable balance of base compensation and long-term equity-based incentive compensation that is closely aligned with the Company's overall performance.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | false |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Daniel Lochner | OPTION | 2025-02-04 | — | — | 32,862 | — | — |
| Daniel Lochner | OPTION | 2025-09-25 | — | — | 9,860 | — | — |
| Alise Reicin | OPTION | 2025-02-04 | — | — | 101,953 | — | — |
| Alise Reicin | OPTION | 2025-09-25 | — | — | 26,710 | — | — |
| Marcella Ruddy | OPTION | 2025-02-04 | — | — | 32,502 | — | — |
| Marcella Ruddy | OPTION | 2025-09-25 | — | — | 9,750 | — | — |
Vehicle mix — grant-date fair value by award type
Grant-level vehicle detail not disclosed.
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Alise Reicin | Option | 3,750 | 51.28 | — |
| Marcella Ruddy | RSU | 5,370 | — | 112,018 |
| Daniel Lochner | RSU | 5,430 | — | 113,270 |
| Alise Reicin | RSU | 8,787 | — | 183,297 |
| Marcella Ruddy | Option | 9,141 | 14.71 | — |
| Daniel Lochner | Option | 9,244 | 14.71 | — |
| Marcella Ruddy | Option | 9,352 | 5.38 | — |
| Alise Reicin | Option | 13,360 | 5.38 | — |
| Alise Reicin | RSU | 14,700 | — | 306,642 |
| Daniel Lochner | Option | 15,000 | 16.8 | — |
| Marcella Ruddy | RSU | 17,876 | — | 372,893 |
| Daniel Lochner | RSU | 18,074 | — | 377,024 |
| Alise Reicin | Option | 25,041 | 14.71 | — |
| Marcella Ruddy | Option | 25,731 | 48.01 | — |
| Daniel Lochner | Option | 26,016 | 48.01 | — |
| Alise Reicin | RSU | 36,047 | — | 751,940 |
| Marcella Ruddy | Option | 51,062 | 16.8 | — |
| Daniel Lochner | Option | 71,292 | 16.8 | — |
| Alise Reicin | Option | 80,713 | 48.01 | — |
| Alise Reicin | Option | 181,000 | 16.8 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Terrance McGuire, M.S., M.B.AIndependent · Not standing for re-election · Departed during FY | $82,118 | — | $198,764 | — | — | $280,882 |
| Phillip B. DonenbergIndependent · Audit (Chair) | 55,000 | — | 198,764 | — | — | 253,764 |
| Stefan Vitorovic, M.S., M.B.AIndependent · Audit · Compensation | 53,118 | — | 198,764 | — | — | 251,882 |
| Praveen Tipirneni, M.D., M.B.AIndependent · Compensation (Chair) | 51,237 | — | 198,764 | — | — | 250,121 |
| Timothy A. Springer, Ph.DIndependent · Nominating and Corporate Governance (Chair) | 49,237 | — | 198,764 | — | — | 248,001 |
| Jessica ChutterIndependent · Newly elected | 0 | — | 0 | — | — | — |
| François Nader, M.DIndependent · Nominating and Corporate Governance | 0 | — | 0 | — | — | — |
Board fee structure and ownership guideline
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $400,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 12,000 / 10,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $290,710 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $290,710 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Tectonic Therapeutic as a peer
Companies that benchmark against AVRO
No companies currently name AVRO as a compensation peer in their most recent disclosure.
This is the complete answer, not a partial one — the list is never padded.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Tectonic Therapeutic, Inc. | 2025 | Alise Reicin | $640,833 | $1,946,853 | $4,373,617 | $372,500 | $7,351,578 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (19 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Alise Reicin. DEF 14A, filed 2026-04-24. Section “Fiscal Year 2025 Summary Compensation Table” · page 27. As printed: 7,351,578. View filing ↗
- Section 01, Daniel Lochner. DEF 14A, filed 2026-04-24. Section “Fiscal Year 2025 Summary Compensation Table” · page 27. As printed: 3,101,114. View filing ↗
- Section 01, Marcella Ruddy. DEF 14A, filed 2026-04-24. Section “Fiscal Year 2025 Summary Compensation Table” · page 27. As printed: 3,069,630. View filing ↗
- Section 03, Daniel Lochner OPTION. DEF 14A, filed 2026-04-24. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Daniel Lochner OPTION. DEF 14A, filed 2026-04-24. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Alise Reicin OPTION. DEF 14A, filed 2026-04-24. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Alise Reicin OPTION. DEF 14A, filed 2026-04-24. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Marcella Ruddy OPTION. DEF 14A, filed 2026-04-24. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Marcella Ruddy OPTION. DEF 14A, filed 2026-04-24. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 08, Terrance McGuire, M.S., M.B.A. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 280,882. View filing ↗
- Section 08, Phillip B. Donenberg. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 253,764. View filing ↗
- Section 08, Stefan Vitorovic, M.S., M.B.A. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 251,882. View filing ↗
- Section 08, Praveen Tipirneni, M.D., M.B.A. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 250,121. View filing ↗
- Section 08, Timothy A. Springer, Ph.D. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 248,001. View filing ↗
- Section 08, Jessica Chutter. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: —. View filing ↗
- Section 08, François Nader, M.D. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: —. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 290,710 + equity 0 + all other 0 = 290,710, summed across the director compensation table rows.
- Tectonic Therapeutic, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Tectonic Therapeutic, Inc.'s own proxy. As printed: 7,351,578. View filing ↗